Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H. Grandas, MD, Kenneth T. Piercy, MD, Michael B. Freeman, MD, Mitchell H. Goldman, MD Journal of Vascular Surgery Volume 32, Issue 3, Pages 506-518 (September 2000) DOI: 10.1067/mva.2000.108641 Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions
Fig. 1 Primary graft patency after femoropopliteal bypass grafting was significantly lower in HRT users compared with nonusers (Kaplan-Meier method, log-rank test, P =.004). HRT, Hormone replacement therapy. Journal of Vascular Surgery 2000 32, 506-518DOI: (10.1067/mva.2000.108641) Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions
Fig. 2 Primary graft patency after above-knee femoropopliteal bypass grafting with prosthetic grafts was significantly lower in HRT users compared with nonusers (Kaplan-Meier method, log-rank test, P =.022). AK, Above-knee; HRT, hormone replacement therapy; PTFE, polytetrafluoroethylene. Journal of Vascular Surgery 2000 32, 506-518DOI: (10.1067/mva.2000.108641) Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions
Fig. 3 Assisted primary graft patency after femoropopliteal bypass grafting was significantly lower in HRT users than in nonusers (Kaplan-Meier method log-rank test, P =.001). HRT, Hormone replacement therapy. Journal of Vascular Surgery 2000 32, 506-518DOI: (10.1067/mva.2000.108641) Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions
Fig. 4 Secondary graft patency after femoropopliteal bypass grafting with prosthetic grafts was significantly lower in HRT users compared with nonusers (Kaplan-Meier method, log-rank test, P =.031). HRT, Hormone replacement therapy; PTFE, polytetrafluoroethylene. Journal of Vascular Surgery 2000 32, 506-518DOI: (10.1067/mva.2000.108641) Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions
Fig. 5 Limb salvage after femoropopliteal bypass grafting was significantly lower in women with previous vascular reconstruction (Kaplan-Meier method, log-rank test, P =.03). Journal of Vascular Surgery 2000 32, 506-518DOI: (10.1067/mva.2000.108641) Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions
Fig. 6 Cumulative patient survival after femoropopliteal bypass grafting was significantly lower in patients with diabetes than in those without (Kaplan-Meier method, log-rank test, P =.011). Journal of Vascular Surgery 2000 32, 506-518DOI: (10.1067/mva.2000.108641) Copyright © 2000 Society for Vascular Surgery and The American Association for Vascular Surgery, a Chapter of the International Society for Cardiovascular Surgery Terms and Conditions